NAYA Biosciences Inc. - Bathi operasional EBITDA NAYA
NAYA Biosciences is implementing the Flex-NK platform to activate immune cells against tumors. This EBITDA chart visualizes current cash flow, where the value of corresponds to the current metric. The asset's value is based on patents in the absence of market sales, while future success in antibody biosynthesis will provide the company with powerful scaling leverage.
NAYA Biosciences Inc. (NAYA) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas NAYA Biosciences|NAYA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal NAYA Biosciences Inc|NAYA - Gunggung utang perusahaan|Utang-utang marang nilai buku NAYA Biosciences|NAYA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NAYA Biosciences|Rasio jangkoan perantara nayabiosciences.com
- statistik bathi lan rasio pasar:
NAYA - Bathi resik|Bathi sing dikarepake NAYA Biosciences|NAYA - Pangali P/E|Kapitalisasi marang proyeksi bathi nayabiosciences.com|NAYA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NAYA Biosciences|NAYA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan NAYA Biosciences|NAYA - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan nayabiosciences.com|NAYA - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep NAYA Biosciences
Pambiji fundamental perusahaan:NAYA Biosciences
NAYA Biosciences is scaling its developments in gene modification for oncology and reproductive medicine, building long-term scientific capital. This trend in absolute profit from core operations measures the daily liquidity inflow net of financial expenses, allowing investors to promptly identify any degradation in the business's operational efficiency prior to the publication of official quarterly reports.
Karo sapa NAYA Biosciences saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|erasca.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA DCTH (Delcath Systems)|Bathi operasional EBITDA Y-mAbs Therapeutics Inc YMAB|AURA: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Candel Therapeutics|ARAY: Bathi operasional EBITDA|SELLAS Life Sciences Group (SLS) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ACTU|CTOR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA HURA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TARA (Protara Tx)|Bathi operasional EBITDA FATE (Fate Therapeutics, Inc.)|Pendapatan operasional sadurunge ngurangi amortisasi Aadi Bioscience, Inc. (WHWK)|TCRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Champions Oncology|xbiotech.com (XBIT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CVM - Pendapatan operasional sadurunge ngurangi amortisasi|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi radiopharmtheranostics.com (RADX)|Bathi operasional EBITDA ARTV|Pendapatan operasional sadurunge ngurangi amortisasi adlainortye.com|Bathi operasional EBITDA VERU (Veru Pharma)|Tempest Therapeutics Corp (TPST) - Bathi sadurunge bunga, pajak, lan amortisasi|XLO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RENB (Renovaro Inc.) - Bathi operasional sadurunge amortisasi|MURA: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Kairos Pharma|OKUR (OnKure Therapeutics, Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi CytoMed GDTC|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Curis, Inc. (CRIS)|Pendapatan operasional sadurunge ngurangi amortisasi apollomicsinc.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tharimmune THAR|ADVB: Bathi operasional sadurunge amortisasi|Genprex, Inc - Bathi operasional EBITDA|CLDI - Bathi operasional EBITDA|SBFM (Sunshine Biopharma, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Xenetic Biosciences, Inc. (XBIO)|SLRX (Salarius Pharmaceuticals, Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA Purple Biotech Ltd|Bathi operasional EBITDA AONC|Bathi operasional sadurunge ngurangi amortisasi BeiGene Ltd BGNE|Bathi operasional EBITDA CKPT (Checkpoint Therapeutics)|Bathi operasional EBITDA elevationoncology.com ELEV|ICAD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IKNA (Ikena Oncology, Inc.) - Bathi operasional sadurunge amortisasi|NTBL: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Viracta Therapeutics, Inc.|MOR (MorphoSys AG) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ascentage.com AAPGV
